We have used magnetic resonance to map the interaction surface of an integral membrane protein for its regulatory target, an integral membrane enzyme. Phospholamban (PLN) regulates cardiac contractility via its modulation of sarco(endo)plasmic reticulum calcium ATPase (SERCA) activity. Impairment of this regulatory process causes heart failure. To map the molecular details of the PLN͞SERCA interaction, we have functionally reconstituted SERCA with labeled PLN in dodecylphosphocholine micelles for highresolution NMR spectroscopy and in both micelles and lipid bilayers for EPR spectroscopy. Differential perturbations in NMR linewidths and chemical shifts, measured as a function of position in the PLN sequence, provide a vivid picture of extensive SERCA contacts in both cytoplasmic and transmembrane domains of PLN and provide structural insight into previously reported functional mutagenesis data. NMR and EPR data show clear and complementary evidence for a dynamic (s-to-ms) equilibrium between two conformational states in the cytoplasmic domain of PLN. These results support the hypothesis that SERCA attracts the cytoplasmic domain of PLN away from the lipid surface, shifting the preexisting equilibrium of PLN conformers toward a structure that is poised to interact with the regulatory target. EPR shows that this conformational switch behaves similarly in micelles and lipid membranes. Based on structural and dynamics data, we propose a model in which PLN undergoes allosteric activation upon encountering SERCA.NMR spectroscopy ͉ protein-protein interaction S arco(endo)plasmic reticulum calcium ATPase (SERCA) designates a family of P-type calcium pumps embedded in the sarco(endo)plasmic reticulum. In muscle, SERCA is a 110-kDa enzyme, containing 10 transmembrane helices and three distinct cytoplasmic domains (1), which restores cytosolic calcium to submicromolar levels via ATP hydrolysis, resulting in relaxation. In cardiac muscle, phospholamban (PLN) regulates SERCA, inhibiting the enzyme at submicromolar Ca 2ϩ (2). After -adrenergic stimulation, PLN is phosphorylated by protein kinase A, reversing SERCA inhibition. SERCA1a, the fast-twitch skeletal muscle isoform, is functionally identical to SERCA2a, the cardiac isoform, both in the presence and absence of PLN (3). Because SERCA1a is a better-characterized enzyme and is readily purified in 100-mg quantities, the present study used this isoform.PLN is a 52-aa, single-pass transmembrane protein that undergoes a dynamic equilibrium between a monomeric inhibitory form and a pentameric storage form (4). PLN has three structural domains, as determined by NMR in dodecylphosphocholine (DPC) micelles (5). The N-terminal cytosolic helix (domain Ia: residues 2-16) is amphipathic, with the hydrophobic face pointing toward the lipid surface (5, 6). A flexible loop (residues 17-21) connects this helix to the C-terminal helix (residues 22-50), introducing an average angle of Ϸ80°between the two helices (5, 6). The C-terminal helix ends with a hydrophobic membrane-embedded seque...